RecruitingPhase 4NCT07308769

Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women


Sponsor

Pharmanutra S.p.a.

Enrollment

146 participants

Start Date

Dec 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare two oral iron treatments, Sucrosomial® Iron and Ferric Maltol, in women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerability with traditional iron supplements, which may limit adherence. Participants will be randomly assigned to receive either Sucrosomial® Iron or Ferric Maltol for 12 weeks. The primary objective is to determine whether Sucrosomial® Iron is as effective as Ferric Maltol in normalizing hemoglobin levels.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria3

  • Female participants ≥ 18 years
  • Mild anemia (11.0 ≤ Hb \< 12 g/dL) or moderate anemia (8.0 \< Hb \< 11 g/dL)
  • Signed informed consent

Exclusion Criteria14

  • Use of iron-containing drugs or supplements within 1 month prior to screening
  • Psychiatric disorders interfering with consent or compliance
  • Active cancer (except fibroids and polyps)
  • Pregnant or breastfeeding women
  • Participation in another interventional study
  • History of poor adherence or inability to comply
  • Use of erythropoietin within 3 months prior to screening
  • Need for blood transfusion or IV iron (per investigator judgment)
  • Severe active IBD (HBI \> 16 for Crohn; CAI \> 12 for ulcerative colitis)
  • Previous bariatric surgery
  • Alcohol abuse
  • Hemochromatosis or iron overload syndromes
  • Hereditary anemias (including thalassemia)
  • Known hypersensitivity to study product ingredients

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSucrosomial® Iron (Sideral® Forte)

Sucrosomial® Iron (Sideral® Forte), 30 mg elemental iron per capsule

DRUGFerric Maltol (Feraccru®)

Ferric Maltol (Feraccru®), 30 mg elemental iron per capsule


Locations(7)

Hospital Quironsalud Barcelona

Barcelona, Spain

Hospital Universitari Dexeus Grupo Quironsalud

Barcelona, Spain

Hospital Universitari Sagrat Cor

Barcelona, Spain

Hospital Quironsalud Malaga

Málaga, Spain

Hospital Quironsalud Malága

Málaga, Spain

Hospital Universitari General De Catalunya

Sant Cugat del Vallès, Spain

Hospital Quironsalud Zaragoza

Zaragoza, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07308769


Related Trials